LifeSci

ProciseDx

ProciseDx provides point-of-care testing that delivers precise, high-quality results—empowering physicians and patients

ProciseDx in the News

ProciseDx has secured a $10.5M Series A to continue funding development and commercialization of its point-of-care diagnostic platform

July 21, 2020

ProciseDx Files 510k and Prepares for EU launch of Novel Point of Care Technology

May 12, 2020

Share on Facebook

Tweet about this on Twitter

Share on LinkedIn

Email this to someone

OTHER COMPANIES

Advanced Image Robotics

Aeromutable

BetFully

ChargeNet Stations

DockWorks

Fenix Space

Fluid Power Ai

2022 Cool Co Logos

Connect Cool Company Intrepid 2022 01

Ivy Energy

Meetlete

OmniSync

PatientPartner

Radicle Science 1

Shadowbox

Tag N Trac

Good Face Project

Trabus Technologies

Vizer

XILO

Yur

Challenger Interactive

Drata

Fulcrum

GrowGuru

Ion Learning

Occuspace

Pandio

Connect San Diego California 2021 Technology Innovation Startup Business Company Personal ai 01

PlusMusic

South 8 Technologies

Xendee

Truvian

Zeriga Health

takelessons

tealium

Abilita Bio

Applied Surgical Robotics ASR

CARI Health

Cooler Heads Care

CRISPR QC

EndoCyclic Therapeutics

Endure Biotherapeutics

f5 Therapeutics

FAScinate Therapeutics

Hai Solutions

Hillhurst Biopharmaceuticals

La Jolla NanoMedical

MediPrint Ophthalmics

MuReva Phototherapy

OrPro Therapeutics

ProciseDx

Styx Biotechnologies

Trestle Biotherapeutics

Connect San Diego California 2021 Life Science Innovation Startup Business Company Abterra Bio 01

Cytonus Therapeutics

Nano Pharma Solutions

Navega Therapeutics

Neuralace Medical

Origami Therapeutics

Thirona Bio

Connect San Diego California 2021 LifeSci BioTech Startup Business Company Concert Health 01

Cybele Microbiome

DTX Pharma Updated Connect San Diego

Hemaflo Therapeutics

CB Therapeutics

TissueNetix

Echo

Welby Health Connect San Diego

Back to All Companies